Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes

The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SAR...

Full description

Saved in:

Bibliographic Details
Published in:	Scientific reports Vol. 11; no. 1; pp. 3455 - 9
Main Authors:	Batra, Mayank, Tian, Runxia, Zhang, Chongxu, Clarence, Emile, Sacher, Camila Sofia, Miranda, Justin Nestor, De La Fuente, Justin Rafa O., Mathew, Megan, Green, Desmond, Patel, Sayari, Bastidas, Maria Virginia Perez, Haddadi, Sara, Murthi, Mukunthan, Gonzalez, Miguel Santiago, Kambali, Shweta, Santos, Kayo H. M., Asif, Huda, Modarresi, Farzaneh, Faghihi, Mohammad, Mirsaeidi, Mehdi
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 10.02.2021 Nature Publishing Group Nature Portfolio
Subjects:	631/250 692/699 Adult Aged Aged, 80 and over Antibodies, Viral - blood Antibodies, Viral - immunology Clinical outcomes Coronaviruses COVID-19 COVID-19 - blood COVID-19 - immunology Dyspnea Female Humanities and Social Sciences Humans Immunoglobulin G Immunoglobulin G - blood Immunoglobulin G - immunology Intensive Care Units Interleukin 6 Length of Stay Lymphocytes Male Middle Aged Mortality multidisciplinary N protein Nucleocapsid Proteins - immunology Nucleocapsids Patients Polymerase chain reaction Prognosis Proteins Regression analysis Respiration SARS-CoV-2 - immunology Science Science (multidisciplinary) Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - immunology
ISSN:	2045-2322, 2045-2322
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S/Co) > 1.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S/Co ratio > 1.5, only S/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection.
AbstractList	The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S/Co) > 1.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S/Co ratio > 1.5, only S/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection. Abstract The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S/Co) > 1.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S/Co ratio > 1.5, only S/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection. The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S/Co) > 1.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S/Co ratio > 1.5, only S/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection.The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG) targeting N protein is detectable in the serum of infected patients. The effect of high titers of IgG against N-protein on clinical outcomes of SARS-CoV2 disease has not been described. We studied 400 RT-PCR confirmed SARS-CoV2 patients to determine independent factors associated with poor outcomes, including Medical Intensive Care Unit (MICU) admission, prolonged MICU stay and hospital admissions, and in-hospital mortality. We also measured serum IgG against the N protein and correlated its concentrations with clinical outcomes. We found that several factors, including Charlson comorbidity Index (CCI), high levels of IL6, and presentation with dyspnea were associated with poor clinical outcomes. It was shown that higher CCI and higher IL6 levels were independently associated with in-hospital mortality. Anti-N protein IgG was detected in the serum of 55 (55%) patients at the time of admission. A high concentration of antibodies, defined as signal to cut off ratio (S/Co) > 1.5 (75 percentile of all measurements), was found in 25 (25%) patients. The multivariable logistic regression models showed that between being an African American, higher CCI, lymphocyte counts, and S/Co ratio > 1.5, only S/Co ratio were independently associated with MICU admission and longer length of stay in hospital. This study recommends that titers of IgG targeting N-protein of SARS-CoV2 at admission is a prognostic factor for the clinical course of disease and should be measured in all patients with SARS-CoV2 infection.
ArticleNumber	3455
Author	Clarence, Emile Zhang, Chongxu Bastidas, Maria Virginia Perez Sacher, Camila Sofia Patel, Sayari Mirsaeidi, Mehdi Modarresi, Farzaneh Faghihi, Mohammad Murthi, Mukunthan Santos, Kayo H. M. De La Fuente, Justin Rafa O. Miranda, Justin Nestor Gonzalez, Miguel Santiago Kambali, Shweta Asif, Huda Batra, Mayank Tian, Runxia Mathew, Megan Haddadi, Sara Green, Desmond
Author_xml	– sequence: 1 givenname: Mayank surname: Batra fullname: Batra, Mayank organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 2 givenname: Runxia surname: Tian fullname: Tian, Runxia organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 3 givenname: Chongxu surname: Zhang fullname: Zhang, Chongxu organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 4 givenname: Emile surname: Clarence fullname: Clarence, Emile organization: School of Medicine, University of Miami – sequence: 5 givenname: Camila Sofia surname: Sacher fullname: Sacher, Camila Sofia organization: School of Medicine, University of Miami – sequence: 6 givenname: Justin Nestor surname: Miranda fullname: Miranda, Justin Nestor organization: School of Medicine, University of Miami – sequence: 7 givenname: Justin Rafa O. surname: De La Fuente fullname: De La Fuente, Justin Rafa O. organization: School of Medicine, University of Miami – sequence: 8 givenname: Megan surname: Mathew fullname: Mathew, Megan organization: School of Medicine, University of Miami – sequence: 9 givenname: Desmond surname: Green fullname: Green, Desmond organization: School of Medicine, University of Miami – sequence: 10 givenname: Sayari surname: Patel fullname: Patel, Sayari organization: School of Medicine, University of Miami – sequence: 11 givenname: Maria Virginia Perez surname: Bastidas fullname: Bastidas, Maria Virginia Perez organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 12 givenname: Sara surname: Haddadi fullname: Haddadi, Sara organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 13 givenname: Mukunthan surname: Murthi fullname: Murthi, Mukunthan organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 14 givenname: Miguel Santiago surname: Gonzalez fullname: Gonzalez, Miguel Santiago organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 15 givenname: Shweta surname: Kambali fullname: Kambali, Shweta organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 16 givenname: Kayo H. M. surname: Santos fullname: Santos, Kayo H. M. organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 17 givenname: Huda surname: Asif fullname: Asif, Huda organization: Division of Pulmonary and Critical Care, University of Miami – sequence: 18 givenname: Farzaneh surname: Modarresi fullname: Modarresi, Farzaneh organization: Express Gene Laboratory – sequence: 19 givenname: Mohammad surname: Faghihi fullname: Faghihi, Mohammad organization: Express Gene Laboratory – sequence: 20 givenname: Mehdi surname: Mirsaeidi fullname: Mirsaeidi, Mehdi email: msm249@med.miami.edu organization: Division of Pulmonary and Critical Care, University of Miami
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33568776$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uk1v1DAUtFARLaV_gAOKxIVLwB9xbF-QqgWWlSoqtdCr5bzYwausvdgJEv8e724LbQ_1xc_vzYxGfvMSHYUYLEKvCX5PMJMfckO4kjWmpJaM4FI9QycUN7ymjNKje_UxOst5jcvhVDVEvUDHjPFWCtGeoOVVHG0VXbUalpUZjA95qr7V2xQn68NucH1-dV0v4g2tyntxebP6RFQFow8ezFjFeYK4sfkVeu7MmO3Z7X2Kfnz5_H3xtb64XK4W5xc1tLid6h5jYLZzkjjSccNASoW5ajnITnSUGduw0oFecuOAu452mAsg0AtHmDLsFK0Oun00a71NfmPSHx2N1_tGTIM2afIwWs0lIUwAOC55YwgzGARzBmPRYgOWFq2PB63t3G1sDzZMyYwPRB9Ogv-ph_hbCym4UrgIvLsVSPHXbPOkNz6DHUcTbJyzpo2UnCuGZYG-fQRdxzmF8lV7FC4LwU1Bvbnv6J-Vu30VgDwAIMWck3Ua_GQmH3cG_agJ1rt06EM6dEmH3qdD78zSR9Q79SdJ7EDKBRwGm_7bfoL1F-cjyNg
CitedBy_id	crossref_primary_10_3390_v13060996 crossref_primary_10_1038_s41541_025_01160_7 crossref_primary_10_3390_covid2030027 crossref_primary_10_1016_j_ijregi_2023_04_003 crossref_primary_10_4103_cmi_cmi_88_24 crossref_primary_10_2478_amb_2024_0005 crossref_primary_10_1016_j_htct_2021_07_008 crossref_primary_10_1080_14760584_2022_2081156 crossref_primary_10_1093_infdis_jiab540 crossref_primary_10_3389_fimmu_2025_1543626 crossref_primary_10_3389_fmicb_2022_842232 crossref_primary_10_1093_infdis_jiad320 crossref_primary_10_1093_jalm_jfab161 crossref_primary_10_1111_febs_16379 crossref_primary_10_3389_fimmu_2023_1206979 crossref_primary_10_1134_S0006297924050080 crossref_primary_10_3390_pathogens10060635 crossref_primary_10_3390_vaccines9121402 crossref_primary_10_3390_ijms232214340 crossref_primary_10_1016_j_jcis_2022_06_119 crossref_primary_10_1038_s41598_022_07489_6 crossref_primary_10_1128_mSphere_00203_21 crossref_primary_10_3390_nu15081905 crossref_primary_10_3390_v16050672 crossref_primary_10_3390_v16101556 crossref_primary_10_1002_ags3_12677 crossref_primary_10_3389_fimmu_2022_811952 crossref_primary_10_3390_v15102018 crossref_primary_10_3390_vaccines9080914 crossref_primary_10_1128_spectrum_00503_23 crossref_primary_10_1128_spectrum_02537_22 crossref_primary_10_1038_s41598_022_16759_2 crossref_primary_10_5495_wjcid_v12_i2_50 crossref_primary_10_1093_cid_ciac797 crossref_primary_10_3390_microorganisms11041015 crossref_primary_10_3389_fpubh_2022_967447 crossref_primary_10_3390_vaccines10050643 crossref_primary_10_1007_s10157_021_02130_8 crossref_primary_10_1038_s41586_022_04683_4 crossref_primary_10_1002_jmv_29527 crossref_primary_10_1093_jalm_jfad042 crossref_primary_10_1371_journal_pone_0281689 crossref_primary_10_1016_j_jcvp_2025_100217 crossref_primary_10_1186_s40779_021_00342_3 crossref_primary_10_1002_eji_202149470 crossref_primary_10_1007_s15010_023_02142_4 crossref_primary_10_1016_j_celrep_2025_115512 crossref_primary_10_1038_s41598_022_12252_y crossref_primary_10_3390_vaccines11050985 crossref_primary_10_1016_j_imlet_2023_05_007 crossref_primary_10_1371_journal_pone_0310860 crossref_primary_10_1371_journal_pone_0310781 crossref_primary_10_1002_smll_202207731 crossref_primary_10_1055_s_0042_1748170 crossref_primary_10_1007_s00430_023_00763_y crossref_primary_10_1186_s12964_024_01665_z crossref_primary_10_1093_ofid_ofae527 crossref_primary_10_1093_oxfimm_iqad001 crossref_primary_10_3389_fimmu_2022_830715 crossref_primary_10_3389_fmed_2022_815389 crossref_primary_10_1371_journal_pone_0318959 crossref_primary_10_1124_pharmrev_120_000285
Cites_doi	10.1007/s11427-019-1665-1 10.1021/acsinfecdis.6b00006 10.1128/JVI.01394-09 10.1016/0021-9681(87)90171-8 10.1186/s13054-020-03175-z 10.4049/jimmunol.173.6.4050 10.1007/978-981-15-0602-4_27 10.1038/s41586-020-2538-8 10.1016/j.meegid.2007.07.004 10.21037/atm.2019.03.04 10.1016/j.jsb.2010.11.021 10.1016/j.jstrokecerebrovasdis.2020.104949 10.1128/JVI.00783-15 10.1038/d41573-020-00073-5 10.1155/2014/157895 10.1038/s41591-018-0186-4 10.1038/s41426-018-0168-0 10.1080/22221751.2020.1773324 10.1093/infdis/128.1.15 10.1146/annurev-immunol-032712-095916 10.15585/mmwr.mm6924e2 10.1002/cti2.1136 10.1038/s41598-018-36972-2 10.1038/srep29201 10.3389/fimmu.2019.00332 10.1093/infdis/128.1.23 10.1093/infdis/jiaa505 10.1186/s12935-017-0460-4 10.1002/art.41285 10.1111/acem.14096 10.1101/2020.03.29.20041962 10.3390/v6082991 10.1017/ice.2020.461 10.1093/ajhp/zxaa287 10.3389/fmed.2020.00459 10.1186/s12985-019-1182-0 10.1128/JVI.74.17.8127-8134.2000 10.1093/infdis/140.4.527 10.1016/S0140-6736(20)30628-0 10.3389/fmed.2020.00231 10.2196/23565 10.1002/eji.1830260618 10.1101/2020.02.18.20023242
ContentType	Journal Article
Copyright	The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA
DOI	10.1038/s41598-021-83108-0
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Natural Science Collection ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic CrossRef Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
EndPage	9
ExternalDocumentID	oai_doaj_org_article_581137ccf5854a13a0c73fa00760ace2 PMC7875990 33568776 10_1038_s41598_021_83108_0
Genre	Journal Article
GrantInformation_xml	– fundername: None – fundername: ;
GroupedDBID	0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK COVID K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM
ID	FETCH-LOGICAL-c606t-d00c3ebf81f1b5a3c88905965c8b7b23ae43890cd85afc5fb2b057c1cd7f139a3
IEDL.DBID	DOA
ISICitedReferencesCount	74
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000684765700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2045-2322
IngestDate	Fri Oct 03 12:53:18 EDT 2025 Tue Nov 04 01:59:22 EST 2025 Sun Nov 09 09:35:08 EST 2025 Tue Oct 07 07:56:27 EDT 2025 Thu Apr 03 07:05:41 EDT 2025 Sat Nov 29 02:21:00 EST 2025 Tue Nov 18 21:08:20 EST 2025 Fri Feb 21 02:38:59 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c606t-d00c3ebf81f1b5a3c88905965c8b7b23ae43890cd85afc5fb2b057c1cd7f139a3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://doaj.org/article/581137ccf5854a13a0c73fa00760ace2
PMID	33568776
PQID	2488035604
PQPubID	2041939
PageCount	9
ParticipantIDs	doaj_primary_oai_doaj_org_article_581137ccf5854a13a0c73fa00760ace2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7875990 proquest_miscellaneous_2488559308 proquest_journals_2488035604 pubmed_primary_33568776 crossref_citationtrail_10_1038_s41598_021_83108_0 crossref_primary_10_1038_s41598_021_83108_0 springer_journals_10_1038_s41598_021_83108_0
PublicationCentury	2000
PublicationDate	2021-02-10
PublicationDateYYYYMMDD	2021-02-10
PublicationDate_xml	– month: 02 year: 2021 text: 2021-02-10 day: 10
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationTitleAlternate	Sci Rep
PublicationYear	2021
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Flipse (CR13) 2016; 6 Schoeman, Fielding (CR7) 2019; 16 Hou (CR23) 2020; 9 Liu (CR24) 2020; 9 Mehta (CR12) 2020; 395 Graham, Baric (CR4) 2010; 84 CR17 Pranata, Huang, Lim, Wahjoepramono, July (CR21) 2020; 29 CR16 CR15 Marchette, Halstead, Falkler, Stenhouse, Nash (CR47) 1973; 128 McBride, Van Zyl, Fielding (CR9) 2014; 6 Henderson (CR43) 2020; 72 Nasiri (CR18) 2020; 7 Gao (CR14) 2020 Gombos (CR26) 2015; 89 Li (CR39) 2020 Tahvildari (CR2) 2020; 7 Bar-On (CR25) 2018; 24 Arvin (CR11) 2020; 584 Charlson, Pompei, Ales, MacKenzie (CR22) 1987; 40 Sun (CR40) 2019; 9 Arvin (CR32) 2020 CR3 He (CR30) 2004; 173 Narayanan, Maeda, Maeda, Makino (CR5) 2000; 74 Berger, Ballo, Stutte (CR42) 1996; 26 Klasse (CR10) 2014 Repsold, Pool, Karodia, Tintinger, Joubert (CR38) 2017; 17 Sagardia, Daniels (CR34) 2020 Stokes (CR1) 2020; 69 Bradfute (CR28) 2020 Corti, Lanzavecchia (CR27) 2013; 31 Neuman (CR6) 2011; 174 Halstead, Shotwell, Casals (CR45) 1973; 128 Jarrett (CR19) 2020 Halstead (CR46) 1979; 140 Uno, Ross (CR44) 2018; 7 Wang (CR37) 2019; 7 Cui, Lin, Yu, Yu, Hu (CR33) 2019; 1206 Liao, Shao, Chen, Chen, Hung (CR36) 2020; 24 Freund (CR35) 2020 Wang (CR29) 2016; 2 Tay, Wiehe, Pollara (CR41) 2019; 10 Sands (CR20) 2020 Surjit, Lal (CR8) 2008; 8 Le Thanh (CR31) 2020; 19 MJ Nasiri (83108_CR18) 2020; 7 MZ Tay (83108_CR41) 2019; 10 T Le Thanh (83108_CR31) 2020; 19 B Cui (83108_CR33) 2019; 1206 T Gao (83108_CR14) 2020 H Hou (83108_CR23) 2020; 9 PJ Klasse (83108_CR10) 2014 L Repsold (83108_CR38) 2017; 17 BW Neuman (83108_CR6) 2011; 174 R McBride (83108_CR9) 2014; 6 N Uno (83108_CR44) 2018; 7 NJ Marchette (83108_CR47) 1973; 128 R Pranata (83108_CR21) 2020; 29 CY Wang (83108_CR37) 2019; 7 J Flipse (83108_CR13) 2016; 6 SB Bradfute (83108_CR28) 2020 83108_CR3 AM Arvin (83108_CR11) 2020; 584 SB Halstead (83108_CR46) 1979; 140 W Li (83108_CR39) 2020 S Berger (83108_CR42) 1996; 26 D Corti (83108_CR27) 2013; 31 EK Stokes (83108_CR1) 2020; 69 LA Henderson (83108_CR43) 2020; 72 K Narayanan (83108_CR5) 2000; 74 P Sun (83108_CR40) 2019; 9 K Sands (83108_CR20) 2020 M Jarrett (83108_CR19) 2020 Y Freund (83108_CR35) 2020 RL Graham (83108_CR4) 2010; 84 X Liu (83108_CR24) 2020; 9 Y He (83108_CR30) 2004; 173 LM Sagardia (83108_CR34) 2020 RB Gombos (83108_CR26) 2015; 89 D Schoeman (83108_CR7) 2019; 16 M Surjit (83108_CR8) 2008; 8 A Tahvildari (83108_CR2) 2020; 7 SB Halstead (83108_CR45) 1973; 128 Y Bar-On (83108_CR25) 2018; 24 AM Arvin (83108_CR32) 2020 83108_CR16 83108_CR15 83108_CR17 Q Wang (83108_CR29) 2016; 2 SC Liao (83108_CR36) 2020; 24 ME Charlson (83108_CR22) 1987; 40 P Mehta (83108_CR12) 2020; 395
References_xml	– year: 2020 ident: CR39 article-title: CD49a(+)CD49b(+) NK cells induced by viral infection reflect an activated state of conventional NK cells publication-title: Sci. China Life Sci. doi: 10.1007/s11427-019-1665-1 – volume: 2 start-page: 361 year: 2016 end-page: 376 ident: CR29 article-title: Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.6b00006 – volume: 84 start-page: 3134 year: 2010 end-page: 3146 ident: CR4 article-title: Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission publication-title: J. Virol. doi: 10.1128/JVI.01394-09 – volume: 40 start-page: 373 year: 1987 end-page: 383 ident: CR22 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J. Chronic Dis. doi: 10.1016/0021-9681(87)90171-8 – ident: CR16 – volume: 24 start-page: 464 year: 2020 ident: CR36 article-title: Incidence and mortality of pulmonary embolism in COVID-19: a systematic review and meta-analysis publication-title: Crit. Care doi: 10.1186/s13054-020-03175-z – volume: 173 start-page: 4050 year: 2004 end-page: 4057 ident: CR30 article-title: Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines publication-title: J. Immunol. doi: 10.4049/jimmunol.173.6.4050 – volume: 1206 start-page: 595 year: 2019 end-page: 634 ident: CR33 article-title: Autophagy and the immune response publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-15-0602-4_27 – volume: 584 start-page: 353 year: 2020 end-page: 363 ident: CR11 article-title: A perspective on potential antibody-dependent enhancement of SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-020-2538-8 – volume: 8 start-page: 397 year: 2008 end-page: 405 ident: CR8 article-title: The SARS-CoV nucleocapsid protein: a protein with multifarious activities publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2007.07.004 – volume: 7 start-page: 134 year: 2019 ident: CR37 article-title: Enhancing autophagy protects platelets in immune thrombocytopenia patients publication-title: Ann. Transl. Med. doi: 10.21037/atm.2019.03.04 – volume: 174 start-page: 11 year: 2011 end-page: 22 ident: CR6 article-title: A structural analysis of M protein in coronavirus assembly and morphology publication-title: J. Struct. Biol. doi: 10.1016/j.jsb.2010.11.021 – volume: 29 start-page: 104949 year: 2020 ident: CR21 article-title: Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression publication-title: J. Stroke Cerebrovasc. Dis. doi: 10.1016/j.jstrokecerebrovasdis.2020.104949 – volume: 89 start-page: 7813 year: 2015 end-page: 7828 ident: CR26 article-title: Inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell HIV-1 transmission publication-title: J. Virol. doi: 10.1128/JVI.00783-15 – volume: 19 start-page: 305 year: 2020 end-page: 306 ident: CR31 article-title: The COVID-19 vaccine development landscape publication-title: Nat. Rev. Drug Discov. doi: 10.1038/d41573-020-00073-5 – year: 2014 ident: CR10 article-title: Neutralization of virus infectivity by antibodies: old problems in new perspectives publication-title: Adv. Biol. doi: 10.1155/2014/157895 – volume: 24 start-page: 1701 year: 2018 end-page: 1707 ident: CR25 article-title: Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals publication-title: Nat. Med. doi: 10.1038/s41591-018-0186-4 – volume: 7 start-page: 167 year: 2018 ident: CR44 article-title: Dengue virus and the host innate immune response publication-title: Emerg. Microbes. Infect. doi: 10.1038/s41426-018-0168-0 – volume: 9 start-page: 1269 year: 2020 end-page: 1274 ident: CR24 article-title: Patterns of IgG and IgM antibody response in COVID-19 patients publication-title: Emerg. Microbes. Infect. doi: 10.1080/22221751.2020.1773324 – volume: 128 start-page: 15 year: 1973 end-page: 22 ident: CR45 article-title: Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection publication-title: J. Infect. Dis. doi: 10.1093/infdis/128.1.15 – volume: 31 start-page: 705 year: 2013 end-page: 742 ident: CR27 article-title: Broadly neutralizing antiviral antibodies publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032712-095916 – volume: 69 start-page: 759 year: 2020 end-page: 765 ident: CR1 article-title: Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020 publication-title: MMWR Morb. Mortal Wkly. Rep. doi: 10.15585/mmwr.mm6924e2 – volume: 9 start-page: e01136 year: 2020 ident: CR23 article-title: Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 publication-title: Clin. Transl. Immunol. doi: 10.1002/cti2.1136 – volume: 9 start-page: 1109 year: 2019 ident: CR40 article-title: NK cells activated through antibody-dependent cell cytotoxicity and armed with degranulation/IFN-gamma production suppress antibody-dependent enhancement of dengue viral infection publication-title: Sci. Rep. doi: 10.1038/s41598-018-36972-2 – volume: 6 start-page: 29201 year: 2016 ident: CR13 article-title: Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses publication-title: Sci. Rep. doi: 10.1038/srep29201 – volume: 10 start-page: 332 year: 2019 ident: CR41 article-title: Antibody-dependent cellular phagocytosis in antiviral immune responses publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.00332 – volume: 128 start-page: 23 year: 1973 end-page: 30 ident: CR47 article-title: Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections publication-title: J. Infect. Dis. doi: 10.1093/infdis/128.1.23 – ident: CR3 – ident: CR15 – year: 2020 ident: CR28 article-title: SARS-CoV-2 neutralizing antibody titers in convalescent plasma and recipients in new Mexico: an open treatment study in COVID-19 patients publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiaa505 – volume: 17 start-page: 89 year: 2017 ident: CR38 article-title: An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia publication-title: Cancer Cell Int. doi: 10.1186/s12935-017-0460-4 – volume: 72 start-page: 1059 year: 2020 end-page: 1063 ident: CR43 article-title: On the alert for cytokine storm: immunopathology in COVID-19 publication-title: Arthritis Rheumatol. doi: 10.1002/art.41285 – ident: CR17 – year: 2020 ident: CR35 article-title: Association between pulmonary embolism and COVID-19 in D patients undergoing CTPA: the PEPCOV international retrospective study publication-title: Acad. Emerg. Med. doi: 10.1111/acem.14096 – year: 2020 ident: CR14 article-title: Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation publication-title: MedRxiv. doi: 10.1101/2020.03.29.20041962 – volume: 6 start-page: 2991 year: 2014 end-page: 3018 ident: CR9 article-title: The coronavirus nucleocapsid is a multifunctional protein publication-title: Viruses doi: 10.3390/v6082991 – year: 2020 ident: CR20 article-title: Patient characteristics and admitting vital signs associated with COVID-19 related mortality among patients admitted with non-critical illness publication-title: Infect. Control Hosp. Epidemiol. doi: 10.1017/ice.2020.461 – year: 2020 ident: CR34 article-title: Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19 publication-title: Am. J. Health Syst. Pharm. doi: 10.1093/ajhp/zxaa287 – volume: 7 start-page: 459 year: 2020 ident: CR18 article-title: COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis publication-title: Front. Med. (Lausanne) doi: 10.3389/fmed.2020.00459 – year: 2020 ident: CR32 article-title: A perspective on potential antibody-dependent enhancement of SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-020-2538-8 – volume: 16 start-page: 1 year: 2019 end-page: 22 ident: CR7 article-title: Coronavirus envelope protein: current knowledge publication-title: Virol. J. doi: 10.1186/s12985-019-1182-0 – volume: 74 start-page: 8127 year: 2000 end-page: 8134 ident: CR5 article-title: Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells publication-title: J. Virol. doi: 10.1128/JVI.74.17.8127-8134.2000 – volume: 140 start-page: 527 year: 1979 end-page: 533 ident: CR46 article-title: In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody publication-title: J. Infect. Dis. doi: 10.1093/infdis/140.4.527 – volume: 395 start-page: 1033 year: 2020 ident: CR12 article-title: COVID-19: consider cytokine storm syndromes and immunosuppression publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(20)30628-0 – volume: 7 start-page: 231 year: 2020 ident: CR2 article-title: Clinical features, diagnosis, and treatment of COVID-19 in hospitalized patients: a systematic review of case reports and case series publication-title: Front. Med. (Lausanne) doi: 10.3389/fmed.2020.00231 – year: 2020 ident: CR19 article-title: Clinical mortality review in a large COVID-19 cohort publication-title: J. Med. Internet Res. doi: 10.2196/23565 – volume: 26 start-page: 1297 year: 1996 end-page: 1301 ident: CR42 article-title: Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830260618 – volume: 6 start-page: 29201 year: 2016 ident: 83108_CR13 publication-title: Sci. Rep. doi: 10.1038/srep29201 – ident: 83108_CR16 – volume: 31 start-page: 705 year: 2013 ident: 83108_CR27 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032712-095916 – volume: 40 start-page: 373 year: 1987 ident: 83108_CR22 publication-title: J. Chronic Dis. doi: 10.1016/0021-9681(87)90171-8 – volume: 19 start-page: 305 year: 2020 ident: 83108_CR31 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/d41573-020-00073-5 – volume: 84 start-page: 3134 year: 2010 ident: 83108_CR4 publication-title: J. Virol. doi: 10.1128/JVI.01394-09 – volume: 16 start-page: 1 year: 2019 ident: 83108_CR7 publication-title: Virol. J. doi: 10.1186/s12985-019-1182-0 – year: 2020 ident: 83108_CR34 publication-title: Am. J. Health Syst. Pharm. doi: 10.1093/ajhp/zxaa287 – volume: 395 start-page: 1033 year: 2020 ident: 83108_CR12 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(20)30628-0 – volume: 8 start-page: 397 year: 2008 ident: 83108_CR8 publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2007.07.004 – volume: 6 start-page: 2991 year: 2014 ident: 83108_CR9 publication-title: Viruses doi: 10.3390/v6082991 – volume: 128 start-page: 23 year: 1973 ident: 83108_CR47 publication-title: J. Infect. Dis. doi: 10.1093/infdis/128.1.23 – volume: 7 start-page: 231 year: 2020 ident: 83108_CR2 publication-title: Front. Med. (Lausanne) doi: 10.3389/fmed.2020.00231 – year: 2014 ident: 83108_CR10 publication-title: Adv. Biol. doi: 10.1155/2014/157895 – year: 2020 ident: 83108_CR32 publication-title: Nature doi: 10.1038/s41586-020-2538-8 – volume: 7 start-page: 459 year: 2020 ident: 83108_CR18 publication-title: Front. Med. (Lausanne) doi: 10.3389/fmed.2020.00459 – volume: 9 start-page: 1269 year: 2020 ident: 83108_CR24 publication-title: Emerg. Microbes. Infect. doi: 10.1080/22221751.2020.1773324 – volume: 174 start-page: 11 year: 2011 ident: 83108_CR6 publication-title: J. Struct. Biol. doi: 10.1016/j.jsb.2010.11.021 – volume: 24 start-page: 464 year: 2020 ident: 83108_CR36 publication-title: Crit. Care doi: 10.1186/s13054-020-03175-z – volume: 7 start-page: 167 year: 2018 ident: 83108_CR44 publication-title: Emerg. Microbes. Infect. doi: 10.1038/s41426-018-0168-0 – volume: 9 start-page: e01136 year: 2020 ident: 83108_CR23 publication-title: Clin. Transl. Immunol. doi: 10.1002/cti2.1136 – year: 2020 ident: 83108_CR39 publication-title: Sci. China Life Sci. doi: 10.1007/s11427-019-1665-1 – year: 2020 ident: 83108_CR14 publication-title: MedRxiv. doi: 10.1101/2020.03.29.20041962 – year: 2020 ident: 83108_CR28 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiaa505 – volume: 74 start-page: 8127 year: 2000 ident: 83108_CR5 publication-title: J. Virol. doi: 10.1128/JVI.74.17.8127-8134.2000 – volume: 9 start-page: 1109 year: 2019 ident: 83108_CR40 publication-title: Sci. Rep. doi: 10.1038/s41598-018-36972-2 – volume: 89 start-page: 7813 year: 2015 ident: 83108_CR26 publication-title: J. Virol. doi: 10.1128/JVI.00783-15 – volume: 173 start-page: 4050 year: 2004 ident: 83108_CR30 publication-title: J. Immunol. doi: 10.4049/jimmunol.173.6.4050 – volume: 2 start-page: 361 year: 2016 ident: 83108_CR29 publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.6b00006 – volume: 128 start-page: 15 year: 1973 ident: 83108_CR45 publication-title: J. Infect. Dis. doi: 10.1093/infdis/128.1.15 – ident: 83108_CR3 – year: 2020 ident: 83108_CR20 publication-title: Infect. Control Hosp. Epidemiol. doi: 10.1017/ice.2020.461 – volume: 140 start-page: 527 year: 1979 ident: 83108_CR46 publication-title: J. Infect. Dis. doi: 10.1093/infdis/140.4.527 – volume: 69 start-page: 759 year: 2020 ident: 83108_CR1 publication-title: MMWR Morb. Mortal Wkly. Rep. doi: 10.15585/mmwr.mm6924e2 – volume: 26 start-page: 1297 year: 1996 ident: 83108_CR42 publication-title: Eur. J. Immunol. doi: 10.1002/eji.1830260618 – volume: 17 start-page: 89 year: 2017 ident: 83108_CR38 publication-title: Cancer Cell Int. doi: 10.1186/s12935-017-0460-4 – year: 2020 ident: 83108_CR19 publication-title: J. Med. Internet Res. doi: 10.2196/23565 – volume: 24 start-page: 1701 year: 2018 ident: 83108_CR25 publication-title: Nat. Med. doi: 10.1038/s41591-018-0186-4 – volume: 7 start-page: 134 year: 2019 ident: 83108_CR37 publication-title: Ann. Transl. Med. doi: 10.21037/atm.2019.03.04 – volume: 584 start-page: 353 year: 2020 ident: 83108_CR11 publication-title: Nature doi: 10.1038/s41586-020-2538-8 – ident: 83108_CR17 – ident: 83108_CR15 doi: 10.1101/2020.02.18.20023242 – volume: 29 start-page: 104949 year: 2020 ident: 83108_CR21 publication-title: J. Stroke Cerebrovasc. Dis. doi: 10.1016/j.jstrokecerebrovasdis.2020.104949 – volume: 72 start-page: 1059 year: 2020 ident: 83108_CR43 publication-title: Arthritis Rheumatol. doi: 10.1002/art.41285 – year: 2020 ident: 83108_CR35 publication-title: Acad. Emerg. Med. doi: 10.1111/acem.14096 – volume: 1206 start-page: 595 year: 2019 ident: 83108_CR33 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-15-0602-4_27 – volume: 10 start-page: 332 year: 2019 ident: 83108_CR41 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.00332
SSID	ssj0000529419
Score	2.580402
Snippet	The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G (IgG)... Abstract The Nucleocapsid Protein (N Protein) of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2) is located in the viral core. Immunoglobulin G...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	3455
SubjectTerms	631/250 692/699 Adult Aged Aged, 80 and over Antibodies, Viral - blood Antibodies, Viral - immunology Clinical outcomes Coronaviruses COVID-19 COVID-19 - blood COVID-19 - immunology Dyspnea Female Humanities and Social Sciences Humans Immunoglobulin G Immunoglobulin G - blood Immunoglobulin G - immunology Intensive Care Units Interleukin 6 Length of Stay Lymphocytes Male Middle Aged Mortality multidisciplinary N protein Nucleocapsid Proteins - immunology Nucleocapsids Patients Polymerase chain reaction Prognosis Proteins Regression analysis Respiration SARS-CoV-2 - immunology Science Science (multidisciplinary) Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - immunology
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BAYkLb2igoCBxA6t-xGvnhMpCSy9L1ULVm-VHvKxUJe1mF4l_j-08quXRC7cktqOxZ8ae8djzAbzh3nLrMUbaugkqXMFRaRxFhlCnC86cM0UCmxCzmTw7K4_6Dbe2P1Y5zIlponaNjXvkuzRKGgvrc_H-4hJF1KgYXe0hNG7CrZglgaaje0fjHkuMYhWk7O_KYCZ327BexTtllKCIsBWeNtajlLb_b7bmn0cmf4ubpuVo__7_duQB3OsN0Xyvk5yHcKOqH8GdDpry52M4OG7Oq7zx-eH8INdzvQhmZD5DKa3Doo4FJ3vHJ2janNI8vE-_nB5-JGU-XLTMm_UqkFO1T-Db_qev08-oB11ANvgyK-QwtqwyXhJPDNfMSllGiB5upRGGMl1FvHRsneQ68NkbaoLJZ4l1wgdrUrOnsFU3dbUNOdcyGCcl48QUhaBcW1NOPBHhl8GJETwDMgy9sn1G8giMca5SZJxJ1bFLBXapxC6FM3g7trno8nFcW_tD5OhYM-bSTh-a5Vz1qqm4JIQJa33wnApNmMZWMK9TzFLbimawMzBS9QreqisuZvB6LA6qGeMtuq6adVcnOGwMywyedeIzUsJCWynEJAOxIVgbpG6W1IvvKf13mGJ5sCEyeDeI4BVZ_x6K59f34gXcpVErItQN3oGt1XJdvYTb9sdq0S5fJbX6BXH3Jek priority: 102 providerName: ProQuest
Title	Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes
URI	https://link.springer.com/article/10.1038/s41598-021-83108-0 https://www.ncbi.nlm.nih.gov/pubmed/33568776 https://www.proquest.com/docview/2488035604 https://www.proquest.com/docview/2488559308 https://pubmed.ncbi.nlm.nih.gov/PMC7875990 https://doaj.org/article/581137ccf5854a13a0c73fa00760ace2
Volume	11
WOSCitedRecordID	wos000684765700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BCxIXxJtAWQWJG1j1I147x3Zpyx66RFuollNkO0lZqUpQk0Xi3zN2skuX54XLKIntaDQztmc09nwAr2TlpKsoJcYVY5IUiSSpLTixjBcmkaIobBLAJtRspheLNLsG9eXPhPXlgXvB7UvNmFDOVejXJoYJQ50SlQkZJePKsPpSlV4Lpvqq3jxNWDrckqFC77e4U_nbZJwRj62FT1s7USjY_zsv89fDkj9lTMNGdHwP7g4eZHzQc34fbpT1A7jdY0p-ewgn8-ayjJsqnl6cxOYCA_-2i2ck1GNY1r7h7GB-RibNOY_xffL-fPqWpfH6hmTcrDo0wrJ9BB-Pjz5M3pEBLYE4DEI6UlDqRGkrzSpmpRFO69Rj60inrbJcmNIDnVNXaGlQQZXlFn01x1yhKnQDjXgMO3VTl08hlkajV5EKyWySKC6Ns-m4Ygp_idGHkhGwteRyN5QS94gWl3lIaQud99LOUdp5kHZOI3i9GfOlL6Tx196HXiGbnr4IdviAppEPppH_yzQi2FurMx9mZptzv2IJ9POSCF5umnFO-USJqctm1ffBSEtQHcGTXvsbTgSO1UqNI1BbdrHF6nZLvfwc6nbj2ihx84_gzdqCfrD1Z1E8-x-ieA53uDd9j2RD92Cnu1qVL-CW-9ot26sR3FQLFagewe7h0Sybj8J8QnrKM08V0t1sepp9-g5NZh5t
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qBQQX9iVQIEhwAquxHU-cA0JlSttRy1B1U2_GdpJhpCops4D6p_iNPDtLNSy99cAtiZ3ITj6_9znPfh_AK1FYYYsoItpmPRJnsSCpyRgxlGU6FjzLTOzFJpLhUB4fp7tL8LPdC-OWVbY20RvqrLLuH_kqc0jj6J_j96ffiFONctHVVkKjhsV2fvYDp2zTd4N1_L6vGdv4eNDfIo2qALFI1mckiyLLc1NIWlAjNLdSpk6DRlhpEsO4zp0geGQzKTR2pDDMIKex1GZJgXRJc3zuFbiKNIIxv1Rwt_un46JmMU2bvTkRl6tT9I9uDxujxCl64dGC__MyAX_jtn8u0fwtTuvd38bt_-3F3YFbDdEO1-qRcReW8vIeXK-lN8_uw-ZedZKHVREORpuhHukx0uRwSHzainHpCvbX9vZJvzpiIZ73Px8N1mkathtJw2o-w-7n0wdweCm9eAjLZVXmjyEUWiL5SrmgJo4TJrQ1aa-gCT4SJ2mJCIC2n1rZJuO6E_44UT7yz6Wq4aEQHsrDQ0UBvOnuOa3zjVxY-4NDUFfT5Qr3F6rJSDWmRwlJKU-sLXBmGGvKdWQTXmgfk9U2ZwGstMBRjQGbqnPUBPCyK0bT4-JJusyreV0HJ6Q8kgE8quHatYTjvTJJegEkC0BeaOpiSTn-6tObowsRyJECeNtC_rxZ_34VTy7uxQu4sXXwaUftDIbbT-EmcyPSyfpEK7A8m8zzZ3DNfp-Np5PnfkiH8OWyh8Iv8qSEKA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4a4yJeuF8CA4IETxA1tuPaeUBotHRUQ6Xa2LS3YDtxqTQloxfQ_hq_jmMn6VQue9sDb03tRLbznYtzjs8H8IJbw42N40iZvBslecKjVOc00oTmKuEsz3XiySbEaCSPjtLxBvxsz8K4tMpWJ3pFnVfGfSPvUIc0hvY56dgmLWLcH7w9-RY5BikXaW3pNGqI7BanP3D7Nn8z7OO7fknp4P3n3oeoYRiIDDruiyiPY8MKbSWxRHPFjJSp46PhRmqhKVOFIwePTS65wklZTTX6N4aYXFh0nRTD516CyyLBYfm0wfHq-46LoCUkbc7pxEx25mgr3Xk2SiLH7oW_1myhpwz4m5_7Z7rmbzFbbwoHN__nRbwFNxoHPNyuJeY2bBTlHbhaU3Ke3oWdveq4CCsbDic7oZqoKbrP4Sjy5SympWvY397bj3rVIQ3xuvfpcNgnadgeMA2r5QKXopjfg4MLmcV92CyrsngIIVcSnbKUcaKTRFCujE67lgh8JG7eBA-AtK89M00ldkcIcpz5jAAmsxoqGUIl81DJ4gBere45qeuQnNv7nUPTqqerIe7_qGaTrFFJGZeEMGGMxR1joghTsRHMKh-rVaagAWy1IMoaxTbPzhAUwPNVM6okF2dSZVEt6z64UWWxDOBBDd3VSBjeK4XoBiDWQL021PWWcvrVlz1H08LRdwrgdQv_s2H9eykenT-LZ3ANJSD7OBztPobr1AmnY_uJt2BzMVsWT-CK-b6YzmdPvXSH8OWiJeEXnSWM7g
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+IgG+against+N-protein+of+SARS-CoV2+in+COVID19+clinical+outcomes&rft.jtitle=Scientific+reports&rft.au=Batra%2C+Mayank&rft.au=Tian%2C+Runxia&rft.au=Zhang%2C+Chongxu&rft.au=Clarence%2C+Emile&rft.date=2021-02-10&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft_id=info:doi/10.1038%2Fs41598-021-83108-0&rft_id=info%3Apmid%2F33568776&rft.externalDocID=PMC7875990
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon